Stock AnalizCore Scientific, Inc. CORZ
Finance: Consumer Services · data as of November 13, 2026
Core Scientific, Inc. (CORZ) is a financial company listed in the US with a market value of about $4.7B. In the twelve months to September 30, 2026 it had revenue of $592M and net income of -$111M, a net margin of -18.8%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is track record (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 40% a year, a 5-year average ROIC of -33%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 83% below the current price.
Score: 0.8 / 5
Checks passed
- Profit margin improving
- 5-year revenue growth above 8% a year
- ROE above 15%
- Share count down over 3 years (buybacks)
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $592M | $319M | $511M | $502M | $640M | $544M | $60M |
| Net income | -$111M | -$289M | -$1.4B | -$246M | -$2.1B | $47M | -$12M |
| Free cash flow | -$1.3B | -$451M | -$52M | $49M | -$179M | -$57M | -$24M |
| EPS (diluted) | $-0.34 | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 | $-0.14 |
| Net margin | -18.8% | -90.5% | -281.6% | -49.1% | -335.2% | 8.7% | -20.2% |
| ROIC | — | -97.5% | -44.0% | 3.3% | — | 4.8% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 21 analysts is $27.24, 88% above the current price; targets range from $16.00 to $38.00; the consensus rating is “Strong buy”; expected EPS is $-0.92 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Core Scientific stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 83% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Core Scientific pay a dividend?
Not currently.
Is Core Scientific a good stock to buy?
We do not give buy or sell advice. Core Scientific scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.